Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

2410-93-7

Methopterine

2410-93-7
22832-87-7

Miconazole nitrate

22832-87-7
72-63-9

Methandrostenolone

72-63-9
50700-49-7

N-Acetylbenzoquinoneimine

50700-49-7
22204-53-1

Naproxene

22204-53-1
1405-10-3

Neomycin sulfate

1405-10-3
04/06/3200

Nafronyl oxalate salt

04/06/3200
70458-96-7

Norfloxacin

70458-96-7
14838-15-4

Norephedrine HCl

14838-15-4
2153-98-2

Norpseudoephedrine HCl

2153-98-2
330-95-0

Nicarbazine

330-95-0
54-11-5

Nicotine

54-11-5
1088-11-5

Nordiazepam

1088-11-5
1689-89-0

Nitroxinil

1689-89-0
5746-86-1

Nornicotine

5746-86-1
4394-00-7

Niflumic acid

4394-00-7
2724726-76-3

Nicardipine Impurity A dihydrochloride

2724726-76-3
31329-57-4

Nafronyl

31329-57-4
112242-14-5

Naloxone-N-oxide

112242-14-5
22083-74-5

rac-Nicotine

22083-74-5